Immigrant neurologists in the physician‐scientist pipeline: an intervenable stenosis

2021 ◽  
Author(s):  
Imama A. Naqvi ◽  
Abhimanyu Mahajan
Keyword(s):  
Physician Scientist

scholarly journals Global Health and the Infectious Diseases Physician-Scientist Workforce

2018 ◽  
Vol 219 (6) ◽  
pp. 1007-1008
Author(s):  
Russell R Kempker ◽  
Henry M Blumberg
Keyword(s):  
Global Health ◽  
Infectious Diseases ◽  
Physician Scientist

scholarly journals Physician Scientist Research Pathway Leading to Certification by the American Board of Pathology

2016 ◽  
Vol 3 ◽  
pp. 237428951663223 ◽  
Author(s):  
Sharon W. Weiss ◽  
Rebecca L. Johnson
Keyword(s):  
Physician Scientist

The Vanishing Physician-Scientist?

JAMA ◽  
2010 ◽  
Vol 304 (11) ◽  
pp. 1241
Author(s):  
Dennis Rosen
Keyword(s):  
Physician Scientist

scholarly journals First steps in the physician-scientist pipeline: a longitudinal study to examine the effects of an undergraduate extracurricular research programme

BMJ Open ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. e048550
Author(s):  
Belinda W C Ommering ◽  
Floris M van Blankenstein ◽  
Friedo W Dekker
Keyword(s):  
Academic Achievement ◽  
Intrinsic Motivation ◽  
Self Efficacy ◽  
Medical Training ◽  
Controlled Trial ◽  
Motivational Factors ◽  
Control Group ◽  
Grade Point ◽  
Research Engagement ◽  
Physician Scientist

ObjectivesMedicine is facing a physician-scientist shortage. By offering extracurricular research programmes (ERPs), the physician-scientist training pipeline could already start in undergraduate phases of medical training. However, previous studies into the effects of ERPs are mainly retrospective and lack baseline measurements and control groups. Therefore, the current study mimics a randomised controlled trial to examine the effects of an ERP.DesignProspective cohort study with baseline measurement and comparable control group.SettingOne cohort of 315 medical undergraduates in one Dutch University Medical Center are surveyed yearly. To examine the effects of the ERP on academic achievement and motivational factors, regression analyses were used to compare ERP students to students showing ERP-interest only, adjusted for relevant baseline scores.ParticipantsOut of the 315 students of the whole cohort, 56 participated within the ERP and are thus included. These ERP students are compared with 38 students showing ERP-interest only (ie, control group).Primary outcome measureAcademic achievement after 2 years (ie, in-time bachelor completion, bachelor grade point average (GPA)) and motivational factors after 18 months (ie, intrinsic motivation for research, research self-efficacy, perceptions of research, curiosity).ResultsERP participation is related to a higher odds of obtaining a bachelor degree in the appointed amount of time (adjusted OR=2.95, 95% CI 0.83 to 10.52). Furthermore, starting the ERP resulted in higher levels of intrinsic motivation for research, also after adjusting for gender, age, first-year GPA and motivational baseline scores (β=0.33, 95% CI 0.04 to 0.63). No effect was found on research self-efficacy beliefs, perceptions of research and curiosity.ConclusionsPrevious research suggested that intrinsic motivation is related to short-term and long-term research engagement. As our findings indicate that starting the ERP is related to increased levels of intrinsic motivation for research, ERPs for undergraduates could be seen as an important first step in the physician-scientist pipeline.

scholarly journals Modeling the developmental origins of pediatric cancer to improve patient outcomes

2021 ◽  
Vol 14 (2) ◽  
Author(s):  
James F. Amatruda
Keyword(s):  
Patient Outcomes ◽  
Pediatric Cancer ◽  
Molecular Mechanisms ◽  
Cellular Transformation ◽  
Genetic Changes ◽  
Current Therapies ◽  
Physician Scientist ◽  
Improve Patient ◽  
Generation Sequencing

ABSTRACT In the treatment of children and adolescents with cancer, multimodal approaches combining surgery, chemotherapy and radiation can cure most patients, but may cause lifelong health problems in survivors. Current therapies only modestly reflect increased knowledge about the molecular mechanisms of these cancers. Advances in next-generation sequencing have provided unprecedented cataloging of genetic aberrations in tumors, but understanding how these genetic changes drive cellular transformation, and how they can be effectively targeted, will require multidisciplinary collaboration and preclinical models that are truly representative of the in vivo environment. Here, I discuss some of the key challenges in pediatric cancer from my perspective as a physician-scientist, and touch on some promising new approaches that have the potential to transform our understanding of these diseases.

Sign in / Sign up

Export Citation Format

Share Document